Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.

NCT00350038 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00350038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00350038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
August 31, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hypertension